Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Avonex

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Avonex was produced by Biogen Idec.

Bio investors react as Clinton tweet pledges pricing crackdown

Bio investors react as Clinton tweet pledges pricing crackdown Biogen (down 5.6%) has been under scrutiny for its pricing policy for first-generation multiple sclerosis drug Avonex (interferon beta-1a), which is among a number of older MS drugs

Biogen Idec plans phase III Alzheimer's trial before year-end

Biogen Idec plans phase III Alzheimer's trial before year-end For the full-year the drug made $2.9bn, a great performance in its second year on the market and more than offsetting declining sales of injectable MS therapy Avonex (interferon ... Biogen Idec was also buoyed by a $40m contribution in the fourth-quarter

Dive in: gaining leadership in a therapeutic area

Dive in: gaining leadership in a therapeutic area Meanwhile Biogen Idec's is the leader in multiple sclerosis (MS) since launching the first interferon beta 1a Avonex in 1996 in the US, re-launching Tysabri in 2006 after a

FDA approves Biogen Idec's long-acting MS therapy

FDA approves Biogen Idec's long-acting MS therapy Plegridy (peginterferon beta-1a) is a long-acting version of Biogen Idec's $3bn-a-year Avonex that has been a mainstay of MS therapy for years but is facing increased ... Plegridy is Biogen Idec's fifth MS treatment to reach the market joining Avonex,

Plegridy approval underlines Biogen Idec's dominance in MS

Plegridy approval underlines Biogen Idec's dominance in MS This includes Avonex, which is one of Biogen's leading products, pulling in sales of around $3bn last year. ... The new drug is dosed once every two weeks - compared to once a week for Avonex - and is the only pegylated version of interferon beta on the

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics